Korea University Anam Hospital
OrganisationROR
Trials
Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism
Collaborator, Phase 4, Not yet recruiting, 2026, 2,300 people, 1 Oct 2026, clinicaltrials.gov
Collaborator, Phase 4, Recruiting, 2023, 2,758 people, 1 Sept 2026, clinicaltrials.gov
No phase, Status unknown, 2026, 160 people, 14 Aug 2026, trialsearch.who.int
CART-BP Prospective Study for Hypertension Control
No phase, Active, not recruiting, 2025, 288 people, 6 Mar 2026, clinicaltrials.gov
Phase 4, Active, not recruiting, 2025, 408 people, 9 Jan 2025, clinicaltrials.gov
Collaborator, Phase 2, Recruiting, 2024, 82 people, 29 Apr 2024, clinicaltrials.gov
Collaborator, Phase 2, Recruiting, 2024, 116 people, 25 Oct 2023, clinicaltrials.gov
Lazertinib/Pemetrexed/Carboplatin After Osimertinib Failure in NSCLC With Brain Metastases
Collaborator, Phase 2, Terminated, 2022, 14 people, 28 Jul 2022, clinicaltrials.gov
Phase 1, Completed, 2020, 48 people, 4 Oct 2021, clinicaltrials.gov
Phase 4, Completed, 2021, 582 people, 1 Apr 2021, clinicaltrials.gov
Phase 4, Status unknown, 2021, 60 people, 22 Jan 2021, clinicaltrials.gov
Collaborator, Phase 4, Status unknown, 2020, 184 people, 29 Oct 2019, clinicaltrials.gov
Phase 1, Completed, 2008, 24 people, 11 Apr 2019, clinicaltrials.gov
Phase 3, Status unknown, 2016, 104 people, 27 Oct 2016, clinicaltrials.gov
Phase 4, Status unknown, 2015, 300 people, 9 Aug 2016, clinicaltrials.gov
Phase 4, Completed, 2013, 1,000 people, 9 Sept 2015, clinicaltrials.gov
Phase 4, Status unknown, 2010, 80 people, 20 Apr 2011, clinicaltrials.gov
Phase 4, Completed, 2011, 94 people, 8 Apr 2011, clinicaltrials.gov
Phase 1, Completed, 2008, 22 people, 16 Feb 2011, clinicaltrials.gov
Phase 4, Completed, 2005, 100 people, 28 Sept 2007, clinicaltrials.gov